|
EDITOR'S NOTE: Big4Bio newsletters will not
be published Nov 27th-29th; they will resume
distribution on Monday, Dec 2nd.
|
|
| *
- may be subscription-only |
|
|
- Curi Bio: Recognized as a 2024 Deloitte Technology
Fast 500 Winner More
- CytoDyn: Appoints Richard Pestell, M.D.,
Ph.D. as Lead Consultant in Oncology More
- FredHutch: Improving Randomized Cancer
Screening Trials - A New Design Based on Late-Stage
Cancer Incidence Reduction More
- PNRI: The TEDDY Study Turns 20 - A New Era for T1D
Insights More
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Setting the Stage for Productive Partnering
Talks During JPM Week Podcast
|
|
|
- Balancing Innovation and Human Insight:
Navigating the Promise and Limitations of AI in
Cancer Research More
- De Novo Proteins to Degrade Unwanted Proteins More
- Fierce 50 Awards Gala Honors Innovators and Leaders
in Biopharma and Healthcare More
- Meet 2024's Fiercest Women in Life
Sciences Podcast
- Q&A With Genetics and Cell Biology Student
Taylor Payton More
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:Seattle Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
- OPPORTUNITY: Senior Director of Business
Development- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs- MA More
- OPPORTUNITY: Chief Financial Officer- Boston, MA More
- OPPORTUNITY: General Manager & Site Head-
Burlington, MA More
- OPPORTUNITY: Director of Epidemiology- Bay Area, CA
More
- OPPORTUNITY: Vice President of Program Leadership,
Boston (Hybrid) More
- OPPORTUNITY: Vice President of Sales &
Marketing, North America- Remote More
- OPPORTUNITY: Vice President or Senior Vice President
of Market Access- San Francisco, CA More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
